Digital pathology startup Deep Lens has unveiled an artificial intelligence (AI) platform that will enable pathologists to diagnose cancer patients more swiftly and accurately.
Novartis is appealing against a High Court ruling that it is lawful for the NHS to prescribe Roche’s Avastin (bevacizumab) in an unlicensed use in wet age-related macular degeneration (AMD)
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
